IMPLANT SITE URTICARIA

This adverse event was reported 98 times

These drugs are most commonly taken by patients reporting IMPLANT SITE URTICARIA:

# Drug Count
0 ETONOGESTREL 83
1 HISTRELIN ACETATE 6
2 ESCITALOPRAM 3
3 SERTRALINE HYDROCHLORIDE 3
4 AFAMELANOTIDE 2
5 ERGOCALCIFEROL 2
6 OXCARBAZEPINE 2
7 ADALIMUMAB 1
8 ALPRAZOLAM 1
9 BREXPIPRAZOLE 1
See all common drugs associated with IMPLANT SITE URTICARIA

IMPLANT SITE URTICARIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFAMELANOTIDE 2 0.0952
1 HISTRELIN ACETATE 6 0.0068
2 ETONOGESTREL 83 0.0014
3 OXCARBAZEPINE 2 0.0001
4 CARIPRAZINE 1 0.0001
5 ZONISAMIDE 1 0.0001
6 ERGOCALCIFEROL 2 0.0001
7 BREXPIPRAZOLE 1 0.0001
8 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1 0.0000
9 SERTRALINE HYDROCHLORIDE 3 0.0000
See all drugs enriched for association with IMPLANT SITE URTICARIA

IMPLANT SITE URTICARIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 83 0.0003
1 Provitamin D2 Compound [EPC] 2 0.0001
2 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
3 Anti-epileptic Agent [EPC] 4 0.0000
4 Thiazide Diuretic [EPC] 1 0.0000
5 Mood Stabilizer [EPC] 1 0.0000
6 Atypical Antipsychotic [EPC] 2 0.0000
7 Osmotic Laxative [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Vitamin B12 [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE URTICARIA